DIAGNOS (CVE:ADK) Hits New 52-Week High – What’s Next?

DIAGNOS Inc. (CVE:ADK)’s stock price reached a new 52-week high on Thursday . The stock traded as high as C$0.41 and last traded at C$0.40, with a volume of 1041344 shares traded. The stock had previously closed at C$0.39.

DIAGNOS Price Performance

The stock’s 50 day moving average price is C$0.26 and its 200-day moving average price is C$0.26. The company has a quick ratio of 0.68, a current ratio of 1.49 and a debt-to-equity ratio of 204.05. The stock has a market capitalization of C$45.15 million, a PE ratio of -9.38 and a beta of -0.14.

Insider Transactions at DIAGNOS

In related news, Director Robert Dunn acquired 200,000 shares of the stock in a transaction on Wednesday, July 29th. The stock was bought at an average cost of C$0.30 per share, with a total value of C$60,000.00. Following the transaction, the director directly owned 2,117,778 shares in the company, valued at approximately C$635,333.40. This represents a 10.43% increase in their ownership of the stock. Over the last three months, insiders have bought 328,571 shares of company stock valued at $96,000. 16.81% of the stock is owned by insiders.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.